PBM reform, telehealth extended as U.S. Congress strikes health deal
VIRGINIA, UNITED STATES — In a move to advance stalled health policies and prevent a government funding gap, Congressional leaders on January 20 struck a bipartisan health care deal that could provide short-term certainty for hospitals, clinics, and health systems across the country.
According to a report from Politico, the deal is expected to move as part of a four-bill spending package that would fund several federal departments through September 30, 2026.
The agreement enables healthcare providers to continue their essential telehealth and hospital-at-home services programs while drug pricing and insurance subsidy reform efforts remain incomplete.
Telehealth and hospital-at-home: Multi-year extensions
For hospitals and clinics still navigating workforce shortages, rising costs, and uneven patient demand, the proposed extensions offer a measure of operational stability.
The agreement would extend “major telehealth flexibilities” through the end of 2027, allowing providers to continue offering virtual care that expanded rapidly during the pandemic.
Health systems that invested heavily in remote care infrastructure will consider their investment as a success because telehealth has become a primary access method in rural and underserved areas.
The deal would also fund, through fiscal year 2030, a Centers for Medicare & Medicaid Services (CMS) program that reimburses facilities for delivering “hospital-level care in the home.”
The program extension holds great importance for hospitals that face patient overcrowding because hospital administrators now use home-based acute care to create more space for patients while reducing expenses.
In addition, the agreement includes a proposal to allow Medicare coverage for multi-cancer early detection screening tests, a move that could expand preventive care offerings for providers while potentially increasing early diagnoses across health systems.
PBM reform: New Medicare oversight and transparency
The package revives an investigation into pharmacy benefit managers (PBMs), which had been pursued for many years when senior appropriators recommended stricter control of drug intermediaries.
Lawmakers have been working for months on a compromise after a PBM overhaul fell out of a December 2024 funding bill following criticism from then-President-elect Donald Trump and Elon Musk.
For providers, tighter PBM oversight could eventually affect drug pricing dynamics and reimbursement flows, though details remain limited.
Community health centers stand to benefit more directly. In what the article describes as “a major win for Democrats,” the agreement would boost funding for community health centers to $4.6 billion in fiscal year 2026, strengthening safety-net providers that serve uninsured and low-income patients.
Still, uncertainty looms. Conservatives in the House may oppose the deal over spending increases, and the framework is silent on many proposals from President Trump’s “Great Healthcare Plan.”
Notably absent is a revival of enhanced Affordable Care Act subsidies, which expired last year and are driving higher premiums—an issue providers say could once again increase uncompensated care burdens.
For now, the deal offers providers incremental gains rather than sweeping reform, underscoring Congress’s focus on short-term stability over structural change.
